FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
The lawsuit is the second filed this week saying Medicare’s new negotiating authority is unconstitutional. Source link
The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. Source link
PoliticsHealth PolicyMillions could lose coverage as their eligibility is reviewed, with financial effects rippling through the healthcare industry Source link
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
Drugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing...
Federal prosecutors have charged about 20 people in the past two weeks with allegedly engaging in various fraud schemes related...
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...
A collection agent for Medicare service providers is suing one of the dozens of trusts established by bankrupt asbestos manufacturers...